Cristina de Leon

Intracavitary Placement of Autologous Lymphokine-Activated Killer (LAK) Cells after Resection of Recurrent Glioblastoma

Robert O. Dillman, Christopher Duma, Patric M. Schiltz et al. · Journal of Immunotherapy · 2004 · 118 citations

Medicine, Oncology, Surgery +17

Tumor Stem Cell Antigens as Consolidative Active Specific Immunotherapy

Robert O. Dillman, Andrew N. Cornforth, Carol DePriest et al. · Journal of Immunotherapy · 2012 · 77 citations

Medicine, Immunology, Oncology +17

Phase II Trial of Dendritic Cells Loaded with Antigens from Self-Renewing, Proliferating Autologous Tumor Cells as Patient-Specific Antitumor Vaccines in Patients with Metastatic Melanoma: Final Report

Robert O. Dillman, Senthamil R. Selvan, Patric M. Schiltz et al. · Cancer Biotherapy and Radiopharmaceuticals · 2009 · 68 citations · Full text

Medicine, Immunology, Oncology +17

Irradiated Cells from Autologous Tumor Cell Lines as Patient-Specific Vaccine Therapy in 125 Patients with Metastatic Cancer: Induction of Delayed-Type Hypersensitivity to Autologous Tumor is Associated with Improved Survival

Robert O. Dillman, Linda D. Beutel, Neil M. Barth et al. · Cancer Biotherapy and Radiopharmaceuticals · 2002 · 46 citations

Medicine, Immunology, Oncology +14

Phase I/II Trial of Melanoma Patient–Specific Vaccine of Proliferating Autologous Tumor Cells, Dendritic Cells, and GM-CSF: Planned Interim Analysis

Robert O. Dillman, Senthamil R. Selvan, Patric M. Schiltz et al. · Cancer Biotherapy and Radiopharmaceuticals · 2004 · 41 citations

Medicine, Immunology, Oncology +17